NEW: Pfizer has asked the FDA to authorize its COVID-19 pill, the company has announced in a press release. Both Merck and Pfizer are working on pills that appear very effective at keeping patients out of the hospital, according to the companies.
Pfizer has asked the Food and Drug Administration to authorize its COVID-19 pill, the company announced in a press release Tuesday.
The Merck medication could be FDA authorized, recommended and available by the end of the year. The FDA's advisory committee is slated to discuss the Merck application on Nov. 30.21 states see at least 10% jump in daily casesThe U.S. daily case average has surged to more than 80,000 -- a 27% jump in three weeks, according to federal data.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Booster jabs for over-40s and Northern Ireland considers Covid passportsFive things you need to know about the coronavirus pandemic this Monday evening.
Read more »
Pfizer agrees to let other companies make its COVID-19 pillLONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.
Read more »
Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pillPfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill.
Read more »
Pfizer agrees to let other companies make its COVID-19 pillDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population. “It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the Medicines Patent Pool, said.
Read more »
Labor Groups Press for Biden’s Covid-19 Vaccine Mandate to Go FurtherThree labor organizations have filed petitions asking the Biden administration to review its Covid-19 vaccine mandate, with some indicating the policy is too limited in applying to only large businesses
Read more »